CRISPR-Cas9: Ethical ang regulatory issues



April 19th, 2016

The CRISPR-Cas9 technology holds great promise for improving plant and animal production, or even to cure hereditary diseases. It also raises important ethical and legal issues that Bartha Knoppers, director of the Centre of Genomics and Policy at McGill University, presents in this short video.

Discover the use of CRISPR-Cas9 in the health sector, as well as in natural sciences and technologies in Québec.